These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1837 related items for PubMed ID: 23526220

  • 21. The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling.
    Scherbakov AM, Sorokin DV, Tatarskiy VV, Prokhorov NS, Semina SE, Berstein LM, Krasil'nikov MA.
    IUBMB Life; 2016 Apr; 68(4):281-92. PubMed ID: 26892736
    [Abstract] [Full Text] [Related]

  • 22. Cationic liposome-mediated nitric oxide synthase gene therapy enhances the antitumor effects of cisplatin in lung cancer.
    Ye S, Yang W, Wang Y, Ou W, Ma Q, Yu C, Ren J, Zhong G, Shi H, Yuan Z, Su X, Zhu W.
    Int J Mol Med; 2013 Jan; 31(1):33-42. PubMed ID: 23128378
    [Abstract] [Full Text] [Related]

  • 23. Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation.
    Groenendijk FH, Mellema WW, van der Burg E, Schut E, Hauptmann M, Horlings HM, Willems SM, van den Heuvel MM, Jonkers J, Smit EF, Bernards R.
    Int J Cancer; 2015 Mar 15; 136(6):1434-44. PubMed ID: 25080865
    [Abstract] [Full Text] [Related]

  • 24. Stimulation of cardiomyogenesis of embryonic stem cells by nitric oxide downstream of AMP-activated protein kinase and mTOR signaling pathways.
    Padmasekar M, Sharifpanah F, Finkensieper A, Wartenberg M, Sauer H.
    Stem Cells Dev; 2011 Dec 15; 20(12):2163-75. PubMed ID: 21470048
    [Abstract] [Full Text] [Related]

  • 25. AMP-activated protein kinase inhibits IL-6-stimulated inflammatory response in human liver cells by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3).
    Nerstedt A, Johansson A, Andersson CX, Cansby E, Smith U, Mahlapuu M.
    Diabetologia; 2010 Nov 15; 53(11):2406-16. PubMed ID: 20652679
    [Abstract] [Full Text] [Related]

  • 26. Adiponectin and metformin additively attenuate IL1β-induced malignant potential of colon cancer.
    Moon HS, Mantzoros CS.
    Endocr Relat Cancer; 2013 Dec 15; 20(6):849-59. PubMed ID: 24157941
    [Abstract] [Full Text] [Related]

  • 27. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.
    Kim YD, Park KG, Lee YS, Park YY, Kim DK, Nedumaran B, Jang WG, Cho WJ, Ha J, Lee IK, Lee CH, Choi HS.
    Diabetes; 2008 Feb 15; 57(2):306-14. PubMed ID: 17909097
    [Abstract] [Full Text] [Related]

  • 28. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
    Wong JC, Bathina M, Fiscus RR.
    J Cell Biochem; 2012 Nov 15; 113(11):3587-98. PubMed ID: 22740515
    [Abstract] [Full Text] [Related]

  • 29. Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo.
    Algire C, Amrein L, Bazile M, David S, Zakikhani M, Pollak M.
    Oncogene; 2011 Mar 10; 30(10):1174-82. PubMed ID: 21102522
    [Abstract] [Full Text] [Related]

  • 30. Activation of AMP-activated protein kinase (AMPK) mediates plumbagin-induced apoptosis and growth inhibition in cultured human colon cancer cells.
    Chen MB, Zhang Y, Wei MX, Shen W, Wu XY, Yao C, Lu PH.
    Cell Signal; 2013 Oct 10; 25(10):1993-2002. PubMed ID: 23712032
    [Abstract] [Full Text] [Related]

  • 31. Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells.
    Kang JI, Hong JY, Lee HJ, Bae SY, Jung C, Park HJ, Lee SK.
    PLoS One; 2015 Oct 10; 10(12):e0144368. PubMed ID: 26656173
    [Abstract] [Full Text] [Related]

  • 32. Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC.
    Moro M, Caiola E, Ganzinelli M, Zulato E, Rulli E, Marabese M, Centonze G, Busico A, Pastorino U, de Braud FG, Vernieri C, Simbolo M, Bria E, Scarpa A, Indraccolo S, Broggini M, Sozzi G, Garassino MC.
    J Thorac Oncol; 2018 Nov 10; 13(11):1692-1704. PubMed ID: 30149143
    [Abstract] [Full Text] [Related]

  • 33. The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models.
    Pignochino Y, Dell'Aglio C, Basiricò M, Capozzi F, Soster M, Marchiò S, Bruno S, Gammaitoni L, Sangiolo D, Torchiaro E, D'Ambrosio L, Fagioli F, Ferrari S, Alberghini M, Picci P, Aglietta M, Grignani G.
    Clin Cancer Res; 2013 Apr 15; 19(8):2117-31. PubMed ID: 23434734
    [Abstract] [Full Text] [Related]

  • 34. Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells.
    Della Corte CM, Ciaramella V, Di Mauro C, Castellone MD, Papaccio F, Fasano M, Sasso FC, Martinelli E, Troiani T, De Vita F, Orditura M, Bianco R, Ciardiello F, Morgillo F.
    Oncotarget; 2016 Jan 26; 7(4):4265-78. PubMed ID: 26673006
    [Abstract] [Full Text] [Related]

  • 35. AMPK/TSC2/mTOR-signaling intermediates are not necessary for LKB1-mediated nuclear retention of PTEN tumor suppressor.
    Liu JL, Mao Z, Gallick GE, Yung WK.
    Neuro Oncol; 2011 Feb 26; 13(2):184-94. PubMed ID: 21123367
    [Abstract] [Full Text] [Related]

  • 36. A potent oncolytic adenovirus selectively blocks the STAT3 signaling pathway and potentiates cisplatin antitumor activity in ovarian cancer.
    Han Z, Hong Z, Gao Q, Chen C, Hao Z, Ji T, Hu W, Yan Y, Feng J, Liao S, Wu P, Wang D, Wang S, Zhou J, Ma D.
    Hum Gene Ther; 2012 Jan 26; 23(1):32-45. PubMed ID: 21875334
    [Abstract] [Full Text] [Related]

  • 37. The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro.
    Dulovic M, Jovanovic M, Xilouri M, Stefanis L, Harhaji-Trajkovic L, Kravic-Stevovic T, Paunovic V, Ardah MT, El-Agnaf OM, Kostic V, Markovic I, Trajkovic V.
    Neurobiol Dis; 2014 Mar 26; 63():1-11. PubMed ID: 24269733
    [Abstract] [Full Text] [Related]

  • 38. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
    Zhang Y, Du XL, Wang CJ, Lin DC, Ruan X, Feng YB, Huo YQ, Peng H, Cui JL, Zhang TT, Wang YQ, Zhang H, Zhan QM, Wang MR.
    Gastroenterology; 2012 Mar 26; 142(3):521-530.e3. PubMed ID: 22108192
    [Abstract] [Full Text] [Related]

  • 39. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
    Nagalingam A, Arbiser JL, Bonner MY, Saxena NK, Sharma D.
    Breast Cancer Res; 2012 Feb 21; 14(1):R35. PubMed ID: 22353783
    [Abstract] [Full Text] [Related]

  • 40. Silencing of the transcription factor STAT3 sensitizes lung cancer cells to DNA damaging drugs, but not to TNFα- and NK cytotoxicity.
    Kulesza DW, Carré T, Chouaib S, Kaminska B.
    Exp Cell Res; 2013 Feb 15; 319(4):506-16. PubMed ID: 23149124
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 92.